These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recurrence of medulloblastoma: violation of Collins' law after two decades. Friedberg MH; David O; Adelman LS; Heilman CB Surg Neurol; 1997 Jun; 47(6):571-4. PubMed ID: 9167782 [TBL] [Abstract][Full Text] [Related]
5. Survival and prognostic factors in a series of adults with medulloblastomas. Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932 [TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma and Collins' law: a critical review of the concept of a period of risk for tumor recurrence and patient survival. Brown WD; Tavaré CJ; Sobel EL; Gilles FH Neurosurgery; 1995 Apr; 36(4):691-7. PubMed ID: 7596498 [TBL] [Abstract][Full Text] [Related]
7. Late recurrence of primitive neuroectodermal tumor/medulloblastoma. Lefkowitz IB; Packer RJ; Ryan SG; Shah N; Alavi J; Rorke LB; Sutton LN; Schut L Cancer; 1988 Aug; 62(4):826-30. PubMed ID: 2840194 [TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma. Zhang R; Zhou L Chin Med J (Engl); 1999 Apr; 112(4):297-301. PubMed ID: 11593525 [TBL] [Abstract][Full Text] [Related]
10. Local control in non-metastatic medulloblastoma. Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891 [TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: conventional radiation therapy in comparison to chemo radiation therapy in the post-operative treatment of high-risk patients. Abd El-Aal HH; Mokhtar MM; Habib E; El-Kashef AT; Fahmy ES J Egypt Natl Canc Inst; 2005 Dec; 17(4):301-7. PubMed ID: 17102823 [TBL] [Abstract][Full Text] [Related]
12. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Gajjar A; Chintagumpala M; Ashley D; Kellie S; Kun LE; Merchant TE; Woo S; Wheeler G; Ahern V; Krasin MJ; Fouladi M; Broniscer A; Krance R; Hale GA; Stewart CF; Dauser R; Sanford RA; Fuller C; Lau C; Boyett JM; Wallace D; Gilbertson RJ Lancet Oncol; 2006 Oct; 7(10):813-20. PubMed ID: 17012043 [TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: clinical presentation and management. Experience at the hospital for sick children, toronto, 1950-1980. Park TS; Hoffman HJ; Hendrick EB; Humphreys RP; Becker LE J Neurosurg; 1983 Apr; 58(4):543-52. PubMed ID: 6827349 [TBL] [Abstract][Full Text] [Related]
14. [Medulloblastoma with neuronal differentiation: a report of five cases]. Nishio S; Morioka T; Inamura T; Takeshita I; Ishihara S; Fukui M No To Shinkei; 2000 May; 52(5):391-7. PubMed ID: 10845206 [TBL] [Abstract][Full Text] [Related]
15. Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996. Roldán G; Brasher P; Vecil G; Senger D; Rewcastle B; Cairncross G; Forsyth P; Hamilton M Can J Neurol Sci; 2008 May; 35(2):210-5. PubMed ID: 18574936 [TBL] [Abstract][Full Text] [Related]
16. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment. Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133 [TBL] [Abstract][Full Text] [Related]
17. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study. Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802 [TBL] [Abstract][Full Text] [Related]
18. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea. Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392 [TBL] [Abstract][Full Text] [Related]
19. Recurrence of medulloblastoma 19 years after the initial diagnosis. Amagasaki K; Yamazaki H; Koizumi H; Hashizume K; Sasaguchi N Childs Nerv Syst; 1999 Sep; 15(9):482-5. PubMed ID: 10502011 [TBL] [Abstract][Full Text] [Related]